Zhejiang Huahai Pharmaceuticals Co., Ltd., a large scaled modern pharmaceutical group that integrates fomulations, APIs and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. It was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003.